Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.886
Filter
1.
Sultan Qaboos Univ Med J ; 24(2): 216-220, 2024 May.
Article in English | MEDLINE | ID: mdl-38828249

ABSTRACT

Objectives: This study aimed to report any suspected adverse drug reactions (ADRs) experienced by all vaccinated staff and students in a tertiary teaching hospital following COVID-19 vaccination. Methods: This retrospective study was conducted during the COVID-19 vaccination campaign at Sultan Qaboos University and Hospital in Muscat, Oman, from August to September 2021. An online survey was generated and sent to all staff and students via email and text messages. An announcement was made on the hospital website with a link to the survey. Results: A total of 8,421 individuals reported being vaccinated at least once with a total of 11,468 doses administered from January to July 2021; 8,014 staff and students received the Pfizer-Biotech vaccine while 3,454 staff and students received the Oxford-AstraZeneca vaccine. The survey received a total of 3,275 responses (response rate = 38.8%). Of these, 741 individuals (22.6%) experienced an ADR after vaccination and 67.2% (n = 498) were females (P <0.001). The majority of the ADRs reported were fever and chills (19.7%) followed by localised pain and swelling at the injection site (18.8%). Other ADRs such as hair loss (0.5%) were reported, and one staff/student reported a clot in the right leg. Among the responders, 27.0% considered their ADRs as mild while 25.0% considered them as severe. Conclusions: In the study cohort, mild symptoms of COVID-19 vaccines were reported. Females experienced more ADRs compared to males. Long-term observation of ADRs to the vaccines and follow-up monitoring should be done on subjects to preclude any unwanted effects.


Subject(s)
COVID-19 Vaccines , COVID-19 , Adult , Female , Humans , Male , Middle Aged , Young Adult , Adverse Drug Reaction Reporting Systems/statistics & numerical data , COVID-19/prevention & control , COVID-19/epidemiology , COVID-19 Vaccines/adverse effects , COVID-19 Vaccines/administration & dosage , Hospitals, University/statistics & numerical data , Oman/epidemiology , Retrospective Studies , Surveys and Questionnaires
2.
Eur J Clin Microbiol Infect Dis ; 43(5): 979-989, 2024 May.
Article in English | MEDLINE | ID: mdl-38517571

ABSTRACT

PURPOSE: This study aimed to investigate the prevalence and viral reactivations of clinical interest in the immunocompromised patient with particular focus on hematologic and solid organ transplant recipients. METHODS: Molecular screening data of CMV, EBV, JCV and BKV from 2011 to 2023 were analyzed. This extensive time span allowed the access to more than 100,000 samples from over 20,000 patients treated at Policlinico Umberto I. It was possible to temporally investigate patient attendance patterns, average age distribution, seasonality of infections, and positivity rates of the analyzed viruses. RESULTS: Between 2019 and 2022 a significant reduction in organ transplants performed and in the positive molecular detection of EBV, JCV and BKV was observed. Additionally, there has been a noteworthy decrease in CMV reactivations, with a reduction of up to 50% starting in 2019. A remarkable reduction of 39% in the rate of CMV viral reactivation has been also achieved in SOT between 2016 and 2023. CONCLUSION: The years following 2019 were profoundly impacted by the COVID-19 pandemic era. This period resulted in a substantial reduction in healthcare services and hospital visits. Furthermore, the introduction of the drug Letermovir in Italy in 2019 demonstrated remarkable efficacy, evidenced by a reduction in CMV reactivations. Additionally, the adoption of a novel clinical approach centered on personalized therapy facilitated improved management of immunocompromised patients.


Subject(s)
Hospitals, University , Immunocompromised Host , Humans , Italy/epidemiology , Hospitals, University/statistics & numerical data , Male , Middle Aged , COVID-19/epidemiology , COVID-19/virology , Female , Virus Activation , Virus Diseases/epidemiology , Virus Diseases/virology , Aged , Adult , JC Virus/genetics , JC Virus/isolation & purification , JC Virus/immunology , BK Virus/genetics , BK Virus/isolation & purification , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/drug therapy , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/immunology , Prevalence , Organ Transplantation/adverse effects , Transplant Recipients/statistics & numerical data , Cytomegalovirus/genetics , Cytomegalovirus/immunology , Polyomavirus Infections/epidemiology , Polyomavirus Infections/virology
3.
Gastroenterol Hepatol ; 47(5): 491-499, 2024 May.
Article in English, Spanish | MEDLINE | ID: mdl-38331316

ABSTRACT

BACKGROUND: Small bowel tumors (SBT) are infrequent and represent a small proportion of digestive neoplasms. There is scarce information about SBT in Latin America. AIM: To describe the epidemiology, clinical characteristics, diagnostic methods, and survival of malignant SBTs. METHODS: Retrospective observational study of adult patients with histopathological diagnosis of SBT between 2007 and 2021 in a university hospital in Chile. RESULTS: A total of 104 patients [51.9% men; mean age 57 years] with SBT. Histological type: neuroendocrine tumor (NET) (43.7%, n=38), gastrointestinal stromal tumors (GIST) (21.8%, n=19), lymphoma (17.2%, n=15) and adenocarcinoma (AC) (11.5%, n=10). GIST was more frequent in duodenum (50%; n=12) and NET in the ileum (65.8%; n=25). Metastasis was observed in 17 cases, most commonly from colon and melanoma. Nausea and vomiting were significantly more often observed in AC (p=0.035), as well as gastrointestinal bleeding in GIST (p=0.007). The most common diagnostic tools were CT and CT enteroclysis with an elevated diagnostic yield (86% and 94% respectively). The 5-year survival of GIST, NET, lymphoma and AC were 94.7% (95%CI: 68.1-99.2), 82.2% (95%CI: 57.6-93.3), 40.0% (95%CI: 16.5-82.8) and 25.9% (95%CI: 4.5-55.7%), respectively. NET (HR 6.1; 95%CI: 2.1-17.2) and GIST (HR 24.4; 95%CI: 3.0-19.8) were independently associated with higher survival compared to AC, adjusted for age and sex. CONCLUSIONS: Malignant SBT are rare conditions and NETs are the most common histological subtype. Clinical presentation at diagnosis, location or complications may suggest a more probable diagnosis. GIST and NET are associated with better survival compared to other malignant subtypes.


Subject(s)
Hospitals, University , Intestinal Neoplasms , Intestine, Small , Humans , Middle Aged , Male , Female , Retrospective Studies , Chile/epidemiology , Hospitals, University/statistics & numerical data , Prognosis , Aged , Intestinal Neoplasms/epidemiology , Intestinal Neoplasms/pathology , Intestinal Neoplasms/diagnosis , Intestine, Small/pathology , Adult , Gastrointestinal Stromal Tumors/epidemiology , Gastrointestinal Stromal Tumors/pathology , Gastrointestinal Stromal Tumors/diagnosis , Aged, 80 and over , Survival Rate , Neuroendocrine Tumors/epidemiology , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/pathology , Adenocarcinoma/epidemiology , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Young Adult , Lymphoma/epidemiology , Lymphoma/diagnosis , Lymphoma/pathology
4.
Tidsskr Nor Laegeforen ; 144(1)2024 01 23.
Article in English, Norwegian | MEDLINE | ID: mdl-38258724

ABSTRACT

BACKGROUND: The Western Norway Regional Health Authority uses SATS Norge (SATS-N), a modified version of the South African Triage Scale, in all accident and emergency departments (A&E) and ambulance services in the region. The purpose of the study was to examine the validity of the paediatric component of SATS-N used for children transported to hospital by ambulance for emergency medical assistance. MATERIAL AND METHOD: We conducted a retrospective observational study which included all children in the age group 0-14 years, admitted by ambulance to A&E at Haukeland University Hospital for emergency medical assistance in the period from January to June 2020. The five triage levels in SATS-N were dichotomised to high triage level (the two highest triage categories) or low triage level (the three lowest triage categories). Sensitivity was calculated as the proportion of patients assigned to the high triage level among those who were directly transferred from A&E to a high dependency unit, and specificity as the proportion of patients assigned to the low triage level among those who were not directly transferred to a high dependency unit. RESULTS: Of a total of 303 patient transports, 270 (89 %) were triaged in the ambulance and 243 (80 %) in the A&E. In the pre-hospital and A&E settings, the sensitivity of SATS-N was 96 % and 88 %, and specificity was 46 % and 60 %, respectively. INTERPRETATION: For children admitted to hospital by ambulance, SATS-N had high sensitivity and low specificity for identifying patients who needed to be directly transferred from A&E to a high dependency unit.


Subject(s)
Ambulances , Emergency Medical Services , Triage , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Acute Disease , Ambulances/statistics & numerical data , Emergency Medical Services/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Hospitals, University/statistics & numerical data , Norway/epidemiology , Retrospective Studies , Transportation of Patients , Triage/classification , Triage/statistics & numerical data
5.
Rev. bras. oftalmol ; 81: e0062, 2022. graf
Article in Portuguese | LILACS | ID: biblio-1407673

ABSTRACT

RESUMO Objetivo conhecer o perfil clínico e cirúrgico de pacientes que realizaram ceratoplastia em um hospital universitário. Métodos Trata-se de um estudo observacional analítico, do tipo transversal. Foram avaliadas as fichas de descrição cirúrgica dos prontuários dos pacientes transplantados nos anos de 2019 e 2020, a fim de analisar dados sociais e clínicos. Os dados foram tratados por meio do programa Microsoft Office Excel 2017. As variáveis numéricas foram analisadas com auxílio da estatística descritiva no programa Bioestat versão 5.3 (frequência, porcentagem, média). As informações descritivas foram analisadas qualitativamente. Resultados Foram realizados 167 procedimentos nesse período, notando-se faixa etária média de 45 anos, indivíduos do sexo masculino, receptores de tecidos doados no Pará ou provenientes do Estado do Ceará. Os transplantes foram majoritariamente ópticos, eletivos, com botão corneano doador em média de 8mm e receptor de 7,5mm. Quanto às indicações, a maioria era decorrente de distrofias corneanas, seguidas de leucoma e perfuração do globo ocular, com predominância da técnica cirúrgica penetrante, sutura interrompida e anestesia local. Conclusão O conhecimento desses dados é importante para considerar que o perfil clínico e cirúrgico dos pacientes do hospital estudado se aproxima da realidade nacional, sobretudo na indicação clínica.


ABSTRACT Objective to investigate the clinical and surgical profile of patients who performed keratoplasty in a university hospital. Methods It is a cross-sectional, observational study. The surgical description from the medical records of transplanted patients in the years 2019 and 2020 was assessed to analyze social and clinical data. Data were processed using the Microsoft Office Excel 2017 program. Numerical variables were analyzed using descriptive statistics in the Bioestat program version 5.3. Descriptive information was analyzed qualitatively. Results 167 procedures were performed in this period, with an average age of 45 years old, male individuals, recipients of tissue donated in Pará or sent from the State of Ceará. Transplants were mostly optic, elective, with an average corneal donor button of 8mm and recipient of 7.5mm. As for the indications, most were due to corneal dystrophies, followed by leukoma and perforation of the eyeball, with a predominance of the penetrating surgical technique, interrupted suture, and local anesthesia. Conclusion The knowledge of these data is important to consider that the clinical and surgical profile of patients in the hospital studied is close to the national reality, especially in clinical indication.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Tissue and Organ Procurement/statistics & numerical data , Corneal Transplantation/statistics & numerical data , Corneal Diseases/epidemiology , Health Profile , Cross-Sectional Studies , Observational Study , COVID-19 , Hospitals, University/statistics & numerical data
6.
Eur Rev Med Pharmacol Sci ; 25(22): 7108-7114, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34859876

ABSTRACT

OBJECTIVE: Concomitant use of drugs not only enhances the therapeutic effect, but may also lead to undesirable interactions. Drug interactions are frequently seen in intensive care patients. In this study, we aimed to determine the frequency and clinical severity of drug interactions in Medical Intensive Care Unit (MICU) patients. PATIENTS AND METHODS: The ordered drugs and blood analysis results of 314 patients aged ≥18 years who stayed in the MICU for at least 24 h between January and December 2020 were evaluated. Using the Lexi-Interact online database, clinically significant types of drug interactions, frequently interacting drug/drug groups, and potential adverse reactions were identified. RESULTS: The average number of drugs in 314 patients was 8.98±5.19. It was determined that polypharmacy was associated with comorbidity and the amount of drug used increased as the number of diagnoses increased. Potential drug-drug interactions were observed in 69.7% of the MICU patients, and it was determined that the amount of interactions increased as the amount of drug used increased. The most common X, D, and C type potential drug-drug interactions, were found between furosemide and salbutamol, enoxaparin and acetylsalicylic acid, ipratropium and potassium chloride, respectively. CONCLUSIONS: Use of frequently interacting drugs in the treatment of critically MICU patients may lead to potential drug-drug interactions and adverse reactions. Daily monitoring and updating of drug therapy can improve patient's quality of life by preventing or reducing potential drug-drug interactions.


Subject(s)
Drug Interactions , Drug-Related Side Effects and Adverse Reactions/epidemiology , Intensive Care Units/statistics & numerical data , Aged , Female , Hospitals, University/statistics & numerical data , Humans , Male , Middle Aged , Retrospective Studies , Turkey/epidemiology
7.
Rev. Rede cuid. saúde ; 15(2): [84-95], dez. 2021.
Article in Portuguese | LILACS | ID: biblio-1349496

ABSTRACT

Segundo o Ministério da Saúde, o número de casos notificados e confirmados de hepatite C no período entre 1999 e 2020 foi de 262.815 casos no Brasil. Em 2016, a OMS estabeleceu como objetivo global que as hepatites não fossem mais um problema de saúde pública em 2030. A partir de 2015, os agentes antivirais de ação direta (DAA) começaram a ser utilizados nessa terapêutica. O tratamento atual da hepatite C com os novos DAA revolucionou o cenário mundial com taxas de cura de até 98%. O objetivo desse artigo é apresentar e discutir o tratamento realizado com DAA em pacientes com hepatite C crônica em um centro de referência no Estado do Rio de Janeiro no período entre novembro de 2015 e julho de 2019. Trata-se de um estudo observacional, prospectivo e descritivo de pacientes com hepatite C crônica tratados com DAA no ambulatório de hepatologia de um hospital de referência. No presente estudo pode ser concluído que a maioria dos pacientes evoluiu para a cura após o tratamento. Foi possível concluir também que os esforços idealizados pela OMS para que o vírus da hepatite C seja erradicado estão ocorrendo de forma positiva e que com as novas DAAs é possível ter um número satisfatoriamente alto de RVS, evitando, assim, desfechos desfavoráveis, como por exemplo, o surgimento de carcinoma hepatocelular.


According to the Ministry of Health, the number of notified and confirmed cases of hepatitis C in the period between 1999 and 2020 was 262,815 cases in Brazil. In 2016, the WHO established as a global goal that hepatitis was no longer a public health problem in 2030. As of 2015, direct action antiviral agents (DAA) began to be used in this therapy. The current treatment of hepatitis C with the new DAA has revolutionized the world scenario with cure rates of up to 98%. The aim of this article is to present and discuss the treatment performed with DAA in patients with chronic hepatitis C in a reference center in the state of Rio de Janeiro between November 2015 and July 2019. This is an observational, prospective and descriptive study of patients with chronic hepatitis C treated with DAA in the hepatology clinic of a reference hospital. In the present study, it can be concluded that most patients evolved to cure after treatment. It was also possible to conclude that the efforts idealized by the WHO to eradicate the hepatitis C virus are occurring in a positive way and that with the new DAAs it is possible to have a satisfactorily high number of SVR, thus avoiding unfavorable outcomes, such as the appearance of hepatocellular carcinoma.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Antiviral Agents/therapeutic use , Hepatitis C, Chronic/drug therapy , Hospitals, University/statistics & numerical data , Brazil/epidemiology , Prospective Studies , Treatment Refusal , Treatment Outcome , Hepatitis C, Chronic/epidemiology , Sociodemographic Factors
8.
JAMA Intern Med ; 181(11): 1471-1478, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34533191

ABSTRACT

Importance: Peripheral intravenous catheters (PVCs) are the most frequently used indwelling devices in hospitals worldwide. Peripheral intravenous catheter bloodstream infections (PVC-BSIs) are rare, but severe and preventable, adverse events. Objective: To investigate the incidence of PVC-BSIs after changing the policy of routine PVC replacement every 96 hours to clinically indicated replacement. Design, Setting, and Participants: This institution-wide, observational cohort study evaluated all patients hospitalized at a large university-affiliated hospital with 10 sites in Western Switzerland with a PVC insertion between January 1, 2016, and February 29, 2020. Exposures: Peripheral intravenous catheters were routinely replaced every 96 hours until March 31, 2018 (baseline period). Between April 1, 2018, and October 15, 2019, PVCs were replaced if clinically indicated (intervention period). From October 16, 2019, PVCs were again routinely replaced every 96 hours (reversion period). Main Outcomes and Measures: The PVC-BSI rates and PVC-BSI incidence rate ratios (IRRs) during each period. Results: A total of 412 631 PVCs with documented catheter duration were included (164 331 patients; median [interquartile range] patient age, 51 [33-72] years; 88 928 [54.1%] female): 241 432 PVCs at baseline, 130 779 at intervention, and 40 420 at reversion. Eleven PVC-BSIs were observed during the baseline period, 46 during the intervention, and 4 during the reversion period. Although the monthly number of PVC-days remained stable during all study periods, the number of monthly inserted PVCs decreased during the intervention period. The number of PVCs still in place more than 4 or more than 7 days was higher during the intervention period compared with the baseline and reversion periods. A significantly increased IRR of PVC-BSIs was observed for the intervention period (IRR, 7.20; 95% CI, 3.65-14.22; P < .001) compared with baseline, whereas during the reversion period there was no significant increase (IRR, 1.35; 95% CI, 0.30 6.17; P = .69). Conclusions and Relevance: The results of this cohort study using a large, prospective surveillance database suggest that replacement of PVCs only when clinically indicated may be associated with an increased risk of PVC-BSI compared with routine replacement. Even if PVC-associated BSI is a rare event, the use of PVCs in most patients makes this outcome relevant.


Subject(s)
Catheter-Related Infections , Catheterization, Peripheral , Guideline Adherence , Catheter-Related Infections/diagnosis , Catheter-Related Infections/epidemiology , Catheter-Related Infections/etiology , Catheter-Related Infections/prevention & control , Catheterization, Peripheral/adverse effects , Catheterization, Peripheral/methods , Catheterization, Peripheral/statistics & numerical data , Duration of Therapy , Female , Guideline Adherence/organization & administration , Guideline Adherence/standards , Hospitals, University/statistics & numerical data , Humans , Incidence , Male , Middle Aged , Outcome and Process Assessment, Health Care , Practice Guidelines as Topic , Switzerland/epidemiology
9.
Antimicrob Resist Infect Control ; 10(1): 114, 2021 08 05.
Article in English | MEDLINE | ID: mdl-34353356

ABSTRACT

BACKGROUND: In healthcare facilities, nosocomial transmissions of respiratory viruses are a major issue. SARS-CoV-2 is not exempt from nosocomial transmission. Our goals were to describe COVID-19 nosocomial cases during the first pandemic wave among patients in a French university hospital and compliance with hygiene measures. METHODS: We conducted a prospective observational study in Grenoble Alpes University Hospital from 01/03/2020 to 11/05/2020. We included all hospitalised patients with a documented SARS-CoV-2 diagnosis. Nosocomial case was defined by a delay of 5 days between hospitalisation and first symptoms. Hygiene measures were evaluated between 11/05/2020 and 22/05/2020. Lockdown measures were effective in France on 17/03/2020 and ended on 11/05/2020. Systematic wearing of mask was mandatory for all healthcare workers (HCW) and visits were prohibited in our institution from 13/03/2021 and for the duration of the lockdown period. RESULTS: Among 259 patients included, 14 (5.4%) were considered as nosocomial COVID-19. Median time before symptom onset was 25 days (interquartile range: 12-42). Eleven patients (79%) had risk factors for severe COVID-19. Five died (36%) including 4 deaths attributable to COVID-19. Two clusters were identified. The first cluster had 5 cases including 3 nosocomial acquisitions and no tested HCWs were positive. The second cluster had 3 cases including 2 nosocomial cases and 4 HCWs were positive. Surgical mask wearing and hand hygiene compliance were adequate for 95% and 61% of HCWs, respectively. CONCLUSIONS: The number of nosocomial COVID-19 cases in our hospital was low. Compliance regarding mask wearing, hand hygiene and lockdown measures drastically reduced transmission of the virus. Monitoring of nosocomial COVID-19 cases during the first wave enabled us to determine to what extent the hygiene measures taken were effective and patients protected. Trial registration Study ethics approval was obtained retrospectively on 30 September 2020 (CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand, IRB 5891).


Subject(s)
COVID-19/epidemiology , Cross Infection/epidemiology , SARS-CoV-2/isolation & purification , Aged , Aged, 80 and over , COVID-19/diagnosis , COVID-19/virology , COVID-19 Testing/methods , Cross Infection/virology , Female , France/epidemiology , Hand Hygiene/methods , Health Personnel , Hospitals, University/statistics & numerical data , Humans , Infection Control/methods , Male , Masks/microbiology , Middle Aged , Pandemics , Prospective Studies , Retrospective Studies
10.
Medicine (Baltimore) ; 100(32): e26847, 2021 Aug 13.
Article in English | MEDLINE | ID: mdl-34397892

ABSTRACT

ABSTRACT: Infectious disease pandemics has a great impact on the use of medical facilities. The purpose of this study was to analyze the effects of coronavirus disease 2019 (COVID-19) on the use of emergency medical facilities in the Republic of Korea. This single-center, retrospective observational study was conducted in a tertiary teaching hospital located in Incheon Metropolitan City, Republic of Korea. We set the pandemic period as February 19, 2020 to April 18, 2020, and the control period was set to the same period in 2018 and 2019. All consecutive patients who visited the emergency department (ED) during the study period were included. Patients were divided into 3 groups according to age (pediatric patients, younger adult patients and older adult patients). The total number, demographics, clinical data, and diagnostic codes of ED patients were analyzed. The total number of ED patients in the pandemic period was lower than that in the control period, which was particularly pronounced for pediatric patients. The proportion of patients who used the 119 ambulances increased in all 3 groups (P  = .002, P < .001, and P = .001), whereas the proportion of patients who visited on foot was decreased (P  = .006, P < .001, and P = .027). In terms of diagnostic codes, a significant decrease was observed in the proportion of certain infectious or parasitic diseases (A00-B99), and respiratory diseases (J00-J99) in the pediatric and younger adult patient groups (P < .001 and P < .001, respectively). The COVID-19 pandemic reduced the number of ED patients; however, the proportion of patients using ambulances increased. In particular, the proportion of patients with diagnostic codes for infectious and respiratory diseases significantly decreased during the pandemic period.


Subject(s)
COVID-19/prevention & control , Emergency Service, Hospital/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , COVID-19/transmission , Child , Child, Preschool , Emergency Service, Hospital/organization & administration , Female , Hospitals, University/organization & administration , Hospitals, University/statistics & numerical data , Humans , Infant , Male , Middle Aged , Republic of Korea , Retrospective Studies
11.
Med J Malaysia ; 76(4): 454-460, 2021 07.
Article in English | MEDLINE | ID: mdl-34305104

ABSTRACT

INTRODUCTION: Knowledge and adequate practice of preventive measures among health care workers (HCWs) are important to reduce the risk of COVID-19 transmission. METHODS: A cross-sectional study was conducted among doctors and nurses in the medical department in Pusat Perubatan Universiti Kebangsaan Malaysia between November 18, 2020 and December 18, 2020 during the third wave of COVID-19 epidemic in Malaysia. We studied the knowledge and practice of preventive measures of COVID-19 among doctors and nurses in the COVID-19 or sudden acute respiratory infection (SARI) wards and general medical wards. Data was collected using a validated self-designed google form online-questionnaire. RESULTS: A total of 407 subjects completed the study and 80.8% were females; 55.8% were aged between 30-39 years; 46.4% were medical doctors. The main source of COVID-19 knowledge was the Ministry of Health Malaysia (MOH) website (35.1%). Majority (97%) had sufficient knowledge and 82% practiced proper preventive measures. Doctors had a higher mean knowledge score compared to nurses (p < 0.001). HCWs working in COVID-19 or SARI wards scored higher in knowledge questions compared to those in the general medical wards (p = 0.020). Nurses practiced better preventive measures (p < 0.001). Good knowledge could not be predicted based on professions (OR: 0.222, 95% CI: 0.048 - 1.028, p = 0.054). Majority were unable to recall the proper steps of donning (85.8%) and doffing (98.5%). CONCLUSIONS: Although majority had good knowledge and practiced proper preventive measures, there was a poor recall in donning and doffing steps regardless of place of practice. The MOH website is a useful platform for tailored continuous medical education and regular updates on COVID-19. Regular training and retraining on donning and doffing of PPE is needed to bridge this gap.


Subject(s)
COVID-19/prevention & control , Cross Infection/prevention & control , Health Knowledge, Attitudes, Practice , Medical Staff, Hospital/statistics & numerical data , Nursing Staff, Hospital/statistics & numerical data , Adult , Cross-Sectional Studies , Female , Hospitals, Teaching/statistics & numerical data , Hospitals, University/statistics & numerical data , Humans , Malaysia , Male , Middle Aged , Surveys and Questionnaires , Young Adult
12.
PLoS One ; 16(7): e0254515, 2021.
Article in English | MEDLINE | ID: mdl-34242375

ABSTRACT

It is difficult for university hospitals to recruit and retain technically efficient surgeons because their missions include teaching and research as well as clinical services. The authors hypothesized that technically efficient surgeons do not continue to provide active clinical services in a university hospital. The authors collected data from all the surgical procedures performed at Teikyo University Hospital from April 1 through September 30 in 2013-2018. The dependent variable was defined as a length of each surgeon's active clinical services measured by month. Data envelopment analysis was employed to calculate each surgeon's technical efficiency score. Five control variables were selected; experience, medical school, surgical volume, gender, and academic ranks. Multiple regression analysis was performed. Efficiency scores had significantly negative association with length of active clinical services. Experience and surgical volume had significantly positive association with length of active clinical services. The other coefficients of control variables were insignificant. Technically efficient surgeons provide shorter active clinical services in a university hospital.


Subject(s)
Hospitals, University/statistics & numerical data , Female , Humans , Male , Operating Rooms/statistics & numerical data , Regression Analysis , Surgeons/statistics & numerical data
13.
PLoS One ; 16(7): e0254581, 2021.
Article in English | MEDLINE | ID: mdl-34265021

ABSTRACT

BACKGROUND: Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt. METHODS: Our study was carried out between May 5 and the end of October 2020. It included all patients requiring admission to Ain Shams University hospitals. An interview questionnaire was used to collect demographic and clinical data. Laboratory tests for all participants included RT-PCR and total antibody assay for SARS-CoV-2. RESULTS: A total of 4,313 subjects were enrolled in our study, with females representing 56% of the sample. Adults and middle-aged individuals represented around 60% of the study sample. The positivity rate of SARS-CoV-2 PCR was 3.84% (95% CI 3.29-4.48), and the SARS-CoV-2 antibody seroprevalence was 29.82% (95% CI: 28.16-31.51). Males showed a higher risk for getting the COVID-19 infection, while middle-age group had significantly higher antibody seroprevalence rates. CONCLUSION: SARS-CoV-2 infection imposes a high burden on the community as detected by high seroprevalence rates.


Subject(s)
COVID-19 Nucleic Acid Testing/statistics & numerical data , COVID-19 Serological Testing/statistics & numerical data , COVID-19/epidemiology , Adolescent , Adult , COVID-19/diagnosis , Egypt , Female , Hospitals, University/statistics & numerical data , Humans , Male , Mass Screening/statistics & numerical data , Middle Aged , Seroepidemiologic Studies
14.
Med Intensiva (Engl Ed) ; 45(6): 325-331, 2021.
Article in English | MEDLINE | ID: mdl-34294231

ABSTRACT

OBJECTIVE: To describe outcomes of critically ill patients with COVID-19, particularly the association of renal replacement therapy to mortality. DESIGN: A single-center prospective observational study was carried out. SETTING: ICU of a tertiary care center. PATIENTS: Consecutive adults with COVID-19 admitted to the ICU. INTERVENTION: Renal replacement therapy. MAIN VARIABLES OF INTEREST: Demographic data, medical history, illness severity, type of oxygen therapy, laboratory data and use of renal replacement therapy to generate a logistic regression model describing independent risk factors for mortality. RESULTS: Of the total of 166 patients, 51% were mechanically ventilated and 26% required renal replacement therapy. The overall hospital mortality rate was 36%, versus 56% for those requiring renal replacement therapy, and 68% for those with both mechanical ventilation and renal replacement therapy. The logistic regression model identified four independent risk factors for mortality: age (adjusted OR 2.8 [95% CI 1.8-4.4] for every 10-year increase), mechanical ventilation (4.2 [1.7-10.6]), need for continuous venovenous hemofiltration (2.3 [1.3-4.0]) and C-reactive protein (1.1 [1.0-1.2] for every 10mg/L increase). CONCLUSIONS: In our cohort, acute kidney injury requiring renal replacement therapy was associated to a high mortality rate similar to that associated to the need for mechanical ventilation, while multiorgan failure necessitating both techniques implied an extremely high mortality risk.


Subject(s)
Acute Kidney Injury/therapy , COVID-19/complications , Critical Illness/therapy , Renal Replacement Therapy , SARS-CoV-2 , Acute Kidney Injury/etiology , Acute Kidney Injury/mortality , Adrenal Cortex Hormones/therapeutic use , Adult , Age Factors , Aged , C-Reactive Protein/analysis , COVID-19/blood , Comorbidity , Continuous Renal Replacement Therapy , Critical Illness/mortality , District of Columbia/epidemiology , Female , Hospital Mortality , Hospitals, University/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Male , Middle Aged , Multiple Organ Failure/etiology , Multiple Organ Failure/mortality , Oxygen Inhalation Therapy/statistics & numerical data , Procedures and Techniques Utilization/statistics & numerical data , Prospective Studies , Renal Replacement Therapy/statistics & numerical data , Respiration, Artificial/statistics & numerical data , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/mortality , Respiratory Distress Syndrome/therapy , Risk Factors , Tertiary Care Centers/statistics & numerical data , Treatment Outcome
15.
PLoS One ; 16(7): e0255289, 2021.
Article in English | MEDLINE | ID: mdl-34297784

ABSTRACT

The objectives of this study were to identify the associated factors with cancerous and precancerous lesions of cervix. In Africa, the incidence of uterine cervical neoplasms varies from one region to another, where most women with uterine cervical neoplasms are seen at an advanced stage. For this reason, uterine cervical neoplasms mass screening reduces the incidence and mortality due to this disease, similar to what is being done in Europe. A cross-sectional analytical study was conducted. Socio-demographic characteristics, gynaecological-obstetrical history, risk factors, data from visual inspection with acetic acid and visual inspection with Lugol, colposcopy impressions and results of cytological analysis were performed. A simple and multiple regression were performed to establish a statistically significant difference between certain factors and the presence of precancerous or cancerous lesions of uterine cervical. In this study, of 63 women diagnosed histologically, 43 had precancerous lesions and 20 had cancerous lesions. we found that being older than 35, having the first intercourse before 18, having an antecedent of STI, being a widow and using of tobacco were risk factors associated with precancerous lesions (p = 0.013 with OR = 3.44 (1.22-9.73), p = 0.009 with OR = 4.07 (1.69-13.08), p < 0.001 with OR = 3.80 (1.94-7.47), p < 0.001 with OR = 9.77 (3.87-24.70) and p < 0.001 with OR = 5.47 (2.60-11.52)) respectively. Only being older than 45, being a widow and using tobacco were risk factors associated with cancerous lesions (p = 0.021 with OR = 2.01 (1.58-3.56), p = 0.02 with OR = 2.96 (2.10-3.87), p = 0.041 with OR = 1.98 (1.46-2.44)) respectively. Among participants diagnosed with uterine cervical neoplasms, there was a significant association with the STI, marital status and smoking. Despite the integration of the detection of precancerous uterine cervical neoplasms lesions into health facilities in Gabon, uterine cervical neoplasms ranks second among women's cancers in terms of incidence and first in terms of mortality.


Subject(s)
Mass Screening/statistics & numerical data , Precancerous Conditions/epidemiology , Uterine Cervical Neoplasms/epidemiology , Adult , Age Factors , Aged , Female , Gabon , Hospitals, University/statistics & numerical data , Humans , Middle Aged , Smoking/epidemiology , Socioeconomic Factors
16.
Plast Reconstr Surg ; 148(2): 443-453, 2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34181596

ABSTRACT

BACKGROUND: Treating chronic osteomyelitis of the lower extremities is challenging. The treatment of acute lower limb trauma by orthoplastic teams has shown good results over the past few decades. This study aimed to characterize surgical outcomes of leg and heel chronic osteomyelitis by an orthoplastic team. METHODS: The cases of 113 consecutive leg and heel chronic osteomyelitis patients undergoing soft-tissue reconstruction with an orthopedic procedure were reviewed in this retrospective single-center observational study. The main objective was to assess surgical outcomes of skin healing and gait recovery at the 1-year follow-up. The secondary objective was to evaluate the global success rate at the last follow-up. RESULTS: The median follow-up was 19.7 months. A free flap was performed for 33 patients (29.2 percent) and a locoregional flap was used in 79 patients (69.9 percent). Seventy-two patients (63.7 percent) had chronic osteomyelitis on continuous bone. The others had a septic pseudarthrosis with a mean bone defect length of 42.9 mm. Forty-four patients (38.9 percent) underwent curettage only, eight (7.1 percent) underwent curettage and cement, 20 (17.7 percent) underwent curettage and bone fixation, and 39 (34.5 percent) underwent the Masquelet technique. At the 1-year follow-up, 72 patients (63.7 percent) had achieved skin healing and had recovered their gait. The success rate at all follow-up time points was 82.3 percent. The median time to achieve skin healing was 6.5 months and that to bone union in cases of septic pseudarthrosis was 7.9 months. CONCLUSION: Orthoplastic management of leg and heel chronic osteomyelitis patients with combined soft-tissue reconstruction using an orthopedic procedure was a viable strategy that offered good results even though the time to complete healing was long. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.


Subject(s)
Curettage/methods , Osteomyelitis/surgery , Plastic Surgery Procedures/methods , Pseudarthrosis/surgery , Skin/injuries , Adolescent , Adult , Aged , Aged, 80 and over , Bone Cements/therapeutic use , Child , Child, Preschool , Chronic Disease/therapy , Curettage/statistics & numerical data , Female , Follow-Up Studies , Foot Bones/microbiology , Foot Bones/pathology , Foot Bones/surgery , Gait/physiology , Heel/pathology , Heel/surgery , Hospitals, University/statistics & numerical data , Humans , Leg/pathology , Leg/surgery , Leg Bones/microbiology , Leg Bones/pathology , Leg Bones/surgery , Male , Middle Aged , Osteomyelitis/complications , Osteomyelitis/microbiology , Osteomyelitis/pathology , Pseudarthrosis/microbiology , Pseudarthrosis/physiopathology , Plastic Surgery Procedures/statistics & numerical data , Recovery of Function , Retrospective Studies , Skin/microbiology , Skin/pathology , Treatment Outcome , Wound Healing , Young Adult
17.
Eur J Hum Genet ; 29(8): 1252-1258, 2021 08.
Article in English | MEDLINE | ID: mdl-34155360

ABSTRACT

Preconception carrier screening offers couples the possibility to receive information about the risk of having a child with a recessive disorder. Since 2016, an expanded carrier screening (ECS) test for 50 severe autosomal recessive disorders has been available at Amsterdam Medical Center, a Dutch university hospital. This mixed-methods study evaluated the experiences of couples that participated in the carrier screening offer, including high-risk participants, as well as participants with a general population risk. All participants received genetic counselling, and pre- (n = 132) and post-test (n = 86) questionnaires and semi-structured interviews (n = 16) were administered. The most important reason to have ECS was to spare a future child a life with a severe disorder (47%). The majority of survey respondents made an informed decision (86%), as assessed by the Multidimensional Measure of Informed Choice. Among the 86 respondents, 27 individual carriers and no new carrier couples were identified. Turn-around time of the test results was considered too long and costs were perceived as too high. Overall, mean levels of anxiety were not clinically elevated. High-risk respondents (n = 89) and pregnant respondents (n = 13) experienced higher levels of anxiety before testing, which decreased after receiving the test result. Although not clinically significant, distress was on average higher for carriers compared to non-carriers (p < 0.0001). All respondents would opt for the test again, and 80.2% would recommend it to others. The results suggest that ECS should ideally be offered before pregnancy, to minimise anxiety. This study could inform current and future implementation initiatives of preconception ECS.


Subject(s)
Genetic Carrier Screening , Genetic Counseling/psychology , Patient Participation , Adult , Female , Genetic Counseling/methods , Hospitals, University/statistics & numerical data , Humans , Male , Patients/psychology
18.
Medicine (Baltimore) ; 100(23): e26216, 2021 Jun 11.
Article in English | MEDLINE | ID: mdl-34115005

ABSTRACT

ABSTRACT: There is debate on the role of estrogens in modulating the risk for atherosclerosis in women. Our purpose was to investigate whether the size of the estrogenic impact was independently associated with variation of carotid intima-media thickness (IMT) in healthy late postmenopausal women. The levels of circulating estrogens have been used in previous studies but the influence of SNPs of the estrogen receptors (ER) α and ß have not been investigated.We performed a crossed-sectional study of 91 women in a university hospital. We used a double approach in which, in addition to the measurement of estradiol levels by ultrasensitive methods, genetic variants (SNPs) associated with differing expression of the ER α and ß genes were assessed. Multivariable analysis was used to examine the association of candidate factors with the value of IMT and plaque detection at both the carotid wall and the sinus.A genotype combination translating reduced gene expression of the ERß was directly associated with IMT at both the carotid wall (P = .001) and the sinus (P = .002). Other predictors of IMT were the levels of glucose, positively associated with IMT at both the carotid wall (P < .001) and the sinus (P = .001), age positively associated with IMT at the sinus (P = .003), and levels of vitamin D, positively associated with IMT at the carotid wall (P = .04).Poorer estrogenic impact, as concordant with a SNP variant imposing reduced expression of the ERß, was directly associated with IMT at both the carotid wall and the sinus. Glucose level, vitamin D only for the carotid wall, and age only for the sinus, also emerged as independent factors in the IMT variance.


Subject(s)
Carotid Intima-Media Thickness/statistics & numerical data , Estrogen Receptor beta/genetics , Postmenopause , Aged , Biomarkers/analysis , Biomarkers/blood , Carotid Intima-Media Thickness/instrumentation , Cross-Sectional Studies , Estrogen Receptor beta/blood , Female , Heart Disease Risk Factors , Hospitals, University/organization & administration , Hospitals, University/statistics & numerical data , Humans , Linear Models , Middle Aged , Polymorphism, Single Nucleotide/genetics , Risk Factors , Ultrasonography/methods
19.
Pediatr Infect Dis J ; 40(11): 981-986, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34108407

ABSTRACT

BACKGROUND: Candidemia is one of the leading causes of bloodstream infections in the pediatric intensive care unit (PICU). The aim of this study was to define characteristics and risk factors for candidemia in the PICU setting and propose a predictive model to identify the patients at risk. METHODS: This was a retrospective matched case-control study in the PICU during a 9-year period. Patients with candidemia were studied and matched with control patients without candidemia. Univariate analysis was performed for potential risk factors and multivariate analysis was conducted to determine the prediction score for candidemia. RESULTS: Forty-two cases of candidemia were matched with 84 control patients. Candida parapsilosis was the most common (71.4%) species. Risk factors independently associated with candidemia were: the use of >2 antibiotics in a maximum period of 4 weeks before the candidemia (odds ratio [OR]: 10.59; 95% confidence interval [CI]: 2.05-54.83), a previous bacterial infection in a maximum period of 4 weeks before the candidemia (OR: 5.56; 95% CI: 1.44-21.5) and the duration of PICU stay of >10 days (OR: 4.22; 95% CI: 1.02-17.41). The proposed predictive scoring system has a sensitivity of 95.24%, specificity of 76.12%, OR 64.0, 95% CI 14.2-288.6, the positive predictive value of 66.67% and the negative predictive value of 96.97%. CONCLUSIONS: Previously reported risk factors for candidemia have been confirmed and some new have been detected. The presented scoring system can help identify patients who would benefit from prophylactic antifungal therapy.


Subject(s)
Candida/pathogenicity , Candidemia/epidemiology , Hospitals, University/statistics & numerical data , Intensive Care Units, Pediatric/statistics & numerical data , Adolescent , Antifungal Agents/therapeutic use , Candidemia/drug therapy , Candidemia/etiology , Case-Control Studies , Child , Child, Preschool , Croatia/epidemiology , Humans , Infant , Infant, Newborn , Odds Ratio , Retrospective Studies , Risk Factors
20.
Clin Transl Oncol ; 23(10): 2046-2056, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34109562

ABSTRACT

PURPOSE: To report healthcare resource use and associated costs in controlled versus uncontrolled carcinoid syndrome (CS) in patients with neuroendocrine tumours. METHODS: A cross-sectional, non-interventional multicentre study was conducted with retrospective data analysis. Resource use was compared between two patient groups: those with controlled CS (> 12 months with no uncontrolled CS episodes) and uncontrolled CS (< 12 months since last uncontrolled episode). Patients were matched for age, sex, and origin and grade of tumour. When no matching patients were available, data from deceased patients were used. Information on healthcare resource use came from review of medical records, patient history and physician reports. Working capacity was assessed using the Work Productivity and Activity Impairment General Health questionnaire. RESULTS: Twenty-six university hospitals in Spain participated, between July 2017 and April 2018. 137 patients were enrolled; 104 were analysed (2 groups of 52). Patients with uncontrolled CS had 10 times more emergency department (ED) visits (mean 1.0 vs 0.10 visits; P = 0.0167), were more likely to have a hospital admission (40.4% vs 19.2%; P = 0.0116) and had longer hospital stays (mean 7.87 vs 2.10 days; P = 0.0178) than those with controlled CS. This corresponded to higher annual hospitalisation costs (mean €5511.59 vs €1457.22; P = 0.028) and ED costs (€161.25 vs €14.85; P = 0.0236). The mean annual total healthcare costs were 60.0% higher in patients with uncontrolled than controlled CS (P = NS). CONCLUSION: This study quantifies higher health resource use, and higher hospitalisation and ED costs in patients with uncontrolled CS. Better control of CS may result 3in lower medical costs.


Subject(s)
Health Care Costs , Health Services Needs and Demand/economics , Malignant Carcinoid Syndrome/economics , Absenteeism , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Direct Service Costs , Emergency Service, Hospital/statistics & numerical data , Female , Health Care Costs/statistics & numerical data , Health Services Needs and Demand/statistics & numerical data , Hospitalization/economics , Hospitalization/statistics & numerical data , Hospitals, University/statistics & numerical data , Humans , Male , Malignant Carcinoid Syndrome/pathology , Malignant Carcinoid Syndrome/therapy , Middle Aged , Neuroendocrine Tumors/economics , Neuroendocrine Tumors/pathology , Neuroendocrine Tumors/therapy , Presenteeism/statistics & numerical data , Retrospective Studies , Spain , Work/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...